AKR1C3
Aldo-keto reductase family 1 member C3
Also known as: AK1C3_HUMAN, DDX, HAKRB, HSD17B5, KIAA0119, PGFS
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P42330
- Gene
- AKR1C3
- Ensembl
- ENSG00000196139
- Chromosome
- 10
- Canonical length
- 323 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol
OverviewNCBI Gene
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9alpha,11beta-PGF2 to PGD2. It may play an important role in the pathogenesis of allergic diseases such as asthma, and may also have a role in controlling cell growth and/or differentiation. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
323 residues, UniProt reviewed canonical sequence.
>P42330|AKR1C3
1 MDSKHQCVKL NDGHFMPVLG FGTYAPPEVP RSKALEVTKL AIEAGFRHID SAHLYNNEEQ
61 VGLAIRSKIA DGSVKREDIF YTSKLWSTFH RPELVRPALE NSLKKAQLDY VDLYLIHSPM
121 SLKPGEELSP TDENGKVIFD IVDLCTTWEA MEKCKDAGLA KSIGVSNFNR RQLEMILNKP
181 GLKYKPVCNQ VECHPYFNRS KLLDFCKSKD IVLVAYSALG SQRDKRWVDP NSPVLLEDPV
241 LCALAKKHKR TPALIALRYQ LQRGVVVLAK SYNEQRIRQN VQVFEFQLTA EDMKAIDGLD
301 RNLHYFNSDS FASHPNYPYS DEYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AKR1C3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 415 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 415 nTPM
- liver: 285 nTPM
- small intestine: 255 nTPM
- gallbladder: 246 nTPM
- stomach: 224 nTPM
- colon: 190 nTPM
Single-cell type
- enterocytes: 515 nCPM
- foveolar cells: 432 nCPM
- hepatocytes: 414 nCPM
- urothelial cells: 389 nCPM
- cholangiocytes: 291 nCPM
- enteric transient amplifying cells: 266 nCPM
Immune cell
- basophil: 245 nTPM
- gdT-cell: 103 nTPM
- total PBMC: 42 nTPM
- plasmacytoid DC: 40 nTPM
- T-reg: 22 nTPM
- NK-cell: 21 nTPM
Brain region
- hypothalamus: 21 nTPM
- basal ganglia: 18 nTPM
- midbrain: 18 nTPM
- medulla oblongata: 14 nTPM
- cerebellum: 13 nTPM
- pons: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AKR1C3.
Disease | ImmuneIEDB
Conditions an epitope on AKR1C3 was assayed in.
- cholangiocarcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.86
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.81
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to calcium ion
- cellular response to jasmonic acid stimulus
- cellular response to prostaglandin D stimulus
- cellular response to starvation
- daunorubicin metabolic process
- doxorubicin metabolic process
- farnesol catabolic process
- G protein-coupled receptor signaling pathway
- keratinocyte differentiation
- male gonad development
- negative regulation of retinoic acid biosynthetic process
- positive regulation of cell population proliferation
- positive regulation of endothelial cell apoptotic process
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of reactive oxygen species metabolic process
- progesterone metabolic process
- prostaglandin metabolic process
- prostanoid biosynthetic process
- regulation of retinoic acid receptor signaling pathway
- regulation of testosterone biosynthetic process
- renal absorption
- response to nutrient
- retinal metabolic process
- retinoid metabolic process
- steroid metabolic process
- testosterone biosynthetic process
- cellular response to corticosteroid stimulus
- cellular response to prostaglandin stimulus
- macromolecule metabolic process
Molecular functions
- 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity
- 3-alpha-hydroxysteroid 3-dehydrogenase [NAD(P)+] activity
- 5-alpha-androstane-3-beta,17-beta-diol dehydrogenase (NADP+) activity
- alcohol dehydrogenase (NADP+) activity
- aldose reductase (NADPH) activity
- all-trans-retinol dehydrogenase (NAD+) activity
- all-trans-retinol dehydrogenase (NADP+) activity
- androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity
- androsterone dehydrogenase [NAD(P)+] activity
- bile acid binding
- Delta4-3-oxosteroid 5beta-reductase activity
- estradiol 17-beta-dehydrogenase [NAD(P)+] activity
- geranylgeranyl reductase activity
- ketosteroid monooxygenase activity
- oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor
- prostaglandin F synthase activity
- prostaglandin H2 endoperoxidase reductase activity
- retinal dehydrogenase (NAD+) activity
- testosterone dehydrogenase (NAD+) activity
- testosterone dehydrogenase (NADP+) activity
- ketoreductase activity
- prostaglandin D2 11-ketoreductase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AKR1C3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AKR1C3 as an antibody target. Whether an autoantibody or antibody against AKR1C3 could matter depends on whether native AKR1C3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AKR1C3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AKR1C3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...